Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP5J2-PTCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R16B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC12A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EP400 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on